BioSpace News Archive

Company recognized as a top workplace for workforce diversity and engagement

Armata Pharmaceuticals, Inc. announced that it will host a Key Opinion Leader meeting on phage-based therapeutics for the treatment of antimicrobial-resistant infections on June 26 from 12:00 – 1:30 PM EDT in New York City.

Ionis Pharmaceuticals, Inc., the leader in antisense therapeutics, announced that management will present a company overview at the BMO Prescription for Success Healthcare Conference at 9:20 a.m. ET on Tuesday, June 25, 2019 in New York, NY.

Datacubed Health’s Mobile Platform Selected to Improve Data Quality and Decrease Patient Burden in Five-Year Washington University Study

Clinical trials of TAC01-CD19 expected to begin in third quarter 2019

Atox Bio announced the Biomedical Advanced Research and Development Authority has exercised the next option on a performance-based contract with for the development of Reltecimod in patients with Necrotizing Soft Tissue Infections.

Company will use funds to scale its Cara Care digital therapeutic for life-interrupting digestive diseases

According to Technavio Research Report “Human Immunodeficiency Virus Rapid Test Kits Market by end-user, and geographic regions is witnessed to grow USD 236.46 million, at a CAGR of 7% from 2019 to 2023”.

The trial evaluated ATI-502 in women and men with AGA. Subjects aged 18-50 years applied ATI-502 to their scalp twice daily for 26 weeks.

Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women’s health clinical research and diagnostic development, today announced the formation of a strategic partnership with DSP Clinical Research, a full-service CRO specializing in reproductive endocrinology/infertility studies.